blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2719690

EP2719690 - AMIDE COMPOUND AND PHARMACEUTICAL APPLICATION THEREFOR [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  27.11.2015
Database last updated on 28.06.2024
Most recent event   Tooltip27.11.2015Application deemed to be withdrawnpublished on 30.12.2015  [2015/53]
Applicant(s)For all designated states
Japan Tobacco Inc.
2-1, Toranomon 2-chome
Minato-ku
Tokyo 105-8422 / JP
[N/P]
Former [2014/16]For all designated states
Japan Tobacco Inc.
2-1, Toranomon 2-chome Minato-ku
Tokyo 105-8422 / JP
Inventor(s)01 / MAEBA, Takaki
c/o Central Pharmaceutical Research Institute of
Japan Tobacco Inc.
1-1 Murasaki-cho
Takatsuki-shi Osaka 569-1125 / JP
02 / MAEDA, Katsuya
c/o Central Pharmaceutical Research Institute of
Japan Tobacco Inc.
1-1 Murasaki-cho
Takatsuki-shi Osaka 569-1125 / JP
03 / KOTOKU, Masayuki
c/o Central Pharmaceutical Research Institute of
Japan Tobacco Inc.
1-1 Murasaki-cho
Takatsuki-shi Osaka 569-1125 / JP
04 / HIRATA, Kazuyuki
c/o CentralPharmaceutical Research Institute of
Japan Tobacco Inc.
1-1 Murasaki-cho
Takatsuki-shi Osaka 569-1125 / JP
05 / SEKI, Noriyoshi
c/o Central Pharmaceutical Research Institute of
Japan Tobacco Inc.
1-1 Murasaki-cho
Takatsuki-shi Osaka 569-1125 / JP
06 / YAMANAKA, Hiroshi
c/o Central Pharmaceutical Research Institute of
Japan Tobacco Inc.
1-1 Murasaki-cho
Takatsuki-shi Osaka 569-1125 / JP
07 / SAKAI, Takayuki
c/o Central Pharmaceutical Research Institute of
Japan Tobacco Inc.
1-1
Murasaki-cho
Takatsuki-shi Osaka 5691125 / JP
08 / HIRASHIMA, Shintaro
c/o Central Pharmaceutical Research Institute of
Japan Tobacco Inc.
1-1 Murasaki-cho
Takatsuki-shi Osaka 569-1125 / JP
09 / OBIKA, Shingo
c/o Central Pharmaceutical Research Institute of
Japan Tobacco Inc.
1-1 Murasaki-cho
Takatsuki-shi Osaka 569-1125 / JP
10 / SHIOZAKI, Makoto
c/o Central Pharmaceutical Research Institute of
Japan Tobacco Inc.
1-1 Murasaki-cho
Takatsuki-shi Osaka 569-1125 / JP
11 / YOKOTA, Masahiro
c/o Central Pharmaceutical Research Institute of
Japan Tobacco Inc.
1-1 Murasaki-cho
Takatsuki-shi Osaka 569-1125 / JP
 [2014/16]
Representative(s)Vossius & Partner Patentanwälte Rechtsanwälte mbB
Siebertstrasse 3
81675 München / DE
[N/P]
Former [2014/16]Vossius & Partner
Siebertstrasse 4
81675 München / DE
Application number, filing date12776819.027.04.2012
WO2012JP61352
Priority number, dateJP2011010033128.04.2011         Original published format: JP 2011100331
US201161482418P04.05.2011         Original published format: US 201161482418 P
[2014/16]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2012147916
Date:01.11.2012
Language:JA
[2012/44]
Type: A1 Application with search report 
No.:EP2719690
Date:16.04.2014
Language:EN
[2014/16]
Search report(s)International search report - published on:JP01.11.2012
(Supplementary) European search report - dispatched on:EP01.12.2014
ClassificationIPC:C07D249/04, A61K31/4192, A61K31/42, A61P1/00, A61P17/04, A61P19/02, A61P25/00, A61P37/02, A61P43/00, C07D261/08, C07D413/06
[2014/16]
CPC:
A61K31/4192 (EP,KR,US); C07D249/04 (EP,CN,KR,US); C07D261/08 (EP,CN,KR,US);
A61K31/42 (EP,KR,US); A61P1/00 (EP); A61P1/04 (EP);
A61P17/00 (EP); A61P17/04 (EP); A61P17/06 (EP);
A61P19/02 (EP); A61P25/00 (EP); A61P27/02 (EP);
A61P29/00 (EP); A61P3/00 (EP); A61P3/10 (EP);
A61P37/00 (EP); A61P37/02 (EP); A61P37/06 (EP);
A61P37/08 (EP); A61P43/00 (EP); C07D413/06 (CN);
C07D417/06 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2014/16]
Extension statesBA27.11.2013
ME27.11.2013
TitleGerman:AMIDVERBINDUNG UND PHARMAZEUTISCHE ANWENDUNG DAVON[2014/16]
English:AMIDE COMPOUND AND PHARMACEUTICAL APPLICATION THEREFOR[2014/16]
French:COMPOSÉ D'AMIDE ET SON UTILISATION EN PHARMACIE[2014/16]
Entry into regional phase27.11.2013Translation filed 
27.11.2013National basic fee paid 
27.11.2013Search fee paid 
27.11.2013Designation fee(s) paid 
27.11.2013Examination fee paid 
Examination procedure27.11.2013Amendment by applicant (claims and/or description)
27.11.2013Examination requested  [2014/16]
30.06.2015Application deemed to be withdrawn, date of legal effect  [2015/53]
06.08.2015Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2015/53]
Divisional application(s)EP14199821.1  / EP2927217
Fees paidRenewal fee
13.03.2014Renewal fee patent year 03
Penalty fee
Additional fee for renewal fee
30.04.201504   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]US6100260  (NAKATSUKA MASASHI [JP], et al) [A] 1-44 * column 1, line 12 - line 14; claims 1,8 *;
 [A]EP2181710  (PHENEX PHARMACEUTICALS AG [DE]) [A] 1-44* paragraph [0001] - paragraph [0025]; claim 1 *;
 [A]WO2010096170  (HARVARD COLLEGE [US], et al) [A] 1-44 * Appendix A; paragraph [0070] - paragraph [0072]; claim 1 * * paragraph [0001] - paragraph [0023] *
International search[A]GB768840  (CASSELLA FARBWERKE MAINKUR AG);
 [A]JPH0789951  (STERLING WINTHROP INC);
 [A]WO9929674  (JANSSEN PHARMACEUTICA NV [BE], et al);
 [A]  - MALONEY,P.R. ET AL., "Identification of a Chemical Tool for the Orphan Nuclear Receptor FXR", J. MED. CHEM., (2000), vol. 43, no. 16, pages 2971 - 4, XP002992679

DOI:   http://dx.doi.org/10.1021/jm0002127
 [A]  - WANG,H. ET AL., "Stereoselective Synthesis of 2-Carbamoyl-2-cyanocyclopropanecarboxylates by Tandem Oxidative Cyclization and Neighboring Group-Assisted Decarboxylation", J. ORG.CHEM., (2010), vol. 75, no. 20, pages 6994 - 7, XP002992679

DOI:   http://dx.doi.org/10.1021/jm0002127
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.